All StatesTennesseeCarter CountyDiana Harshbarger › Evidence
Neutral Bill Mar 16, 2026

Seniors’ Access to Critical Medications Act of 2025

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 2484 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. R. 2484 To amend title XVIII of the Social Security Act to establish an exception to the physician self-referral prohibition for certain outpatient prescription drugs furnished by a physician practice under the Medicare program. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 31, 2025 Mrs. Harshbarger (for herself, Ms. Wasserman Schultz, Mrs. Miller of West Virginia, Mr. Soto, Mr. Crenshaw, and Mr. Davis of North Carolina) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To amend title XVIII of the Social Security Act to establish an exception to the physician self-referral prohibition for certain outpatient prescription drugs furnished by a physician practice under the Medicare program. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Seniors' Access to Critical Medications Act of 2025''. SEC. 2. ESTABLISHING AN EXCEPTION TO THE PHYSICIAN SELF-REFERRAL PROHIBITION FOR CERTAIN OUTPATIENT PRESCRIPTION DRUGS FURNISHED BY A PHYSICIAN PRACTICE UNDER THE MEDICARE PROGRAM. (a) In General.--Section 1877(b) of the Social Security Act (42 U.S.C. 1395nn(b)) is amended by adding at the end the following new paragraph: ``(6) Certain outpatient prescription drugs.-- ``(A) In general.--In the case of designated health services described in subsection (h)(6)(J) that are covered part D drugs (as defined in section 1860

https://www.congress.gov/bill/119th-congress/house-bill/2484
Diana Harshbarger U.S. Representative Richard Hudson U.S. Representative Cosponsor Sarah Elfreth U.S. Representative Cosponsor Jennifer Kiggans U.S. Representative Cosponsor
Health Health personnel Congressional oversight Government studies and investigations Medicare Prescription drugs
Share on X Share on Facebook
← Back to Diana Harshbarger's profile